Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01607905
Title Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced or Metastatic Solid Tumor Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Karyopharm Therapeutics, Inc
Indications
Therapies
Age Groups: adult
Covered Countries USA | DNK | CAN


No variant requirements are available.